BRUKER CORPORATION APIC, Share-based Payment Arrangement, Increase for Cost Recognition
BRUKER CORPORATION (BRKR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $5.20M, a 1.89% decline year-over-year.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $5.50M, a 5.77% increase year-over-year.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.50M, a 5.77% increase year-over-year.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.30M, a 10.42% increase year-over-year.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $21.90M, a 7.88% increase from fiscal 2024.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $20.30M, a 15.34% increase from fiscal 2023.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $17.60M, a 12.10% increase from fiscal 2022.
- BRUKER CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $15.70M, a 8.28% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.20M 10-Q · filed 2026-08-05 | $10.70M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $5.50M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $21.90M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $5.50M 10-Q · filed 2025-11-05 | $10.80M derived: sum of 2 quarters · filed 2026-08-05 | $16.00M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $5.30M 10-Q · filed 2026-08-05 | $10.50M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $5.20M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $20.30M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $5.20M 10-Q · filed 2025-11-05 | $10.00M derived: sum of 2 quarters · filed 2025-11-05 | $14.60M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $4.80M 10-Q · filed 2025-11-05 | $9.40M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $4.60M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $17.60M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $4.60M 10-Q · filed 2024-11-07 | $8.70M derived: sum of 2 quarters · filed 2024-11-07 | $12.80M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $4.10M 10-Q · filed 2024-11-07 | $8.20M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $4.10M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $15.70M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $3.90M 10-Q · filed 2023-11-09 | $7.70M derived: sum of 2 quarters · filed 2023-11-09 | $11.50M derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $3.80M 10-Q · filed 2023-11-09 | $7.60M derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $3.80M 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $14.50M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $3.80M 10-Q · filed 2022-11-04 | $7.40M derived: sum of 2 quarters · filed 2022-11-04 | $10.80M derived: sum of 3 quarters · filed 2022-11-04 | |
| 2021-06-30 | $3.60M 10-Q · filed 2022-11-04 | $7.00M derived: sum of 2 quarters · filed 2022-11-04 | ||
| 2021-03-31 | $3.40M 10-Q · filed 2022-11-04 | |||
| 2020-12-31 | $13.30M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $4.10M 10-Q · filed 2021-11-05 | $6.90M derived: sum of 2 quarters · filed 2021-11-05 | $9.90M derived: sum of 3 quarters · filed 2021-11-05 | |
| 2020-06-30 | $2.80M 10-Q · filed 2021-11-05 | $5.80M derived: sum of 2 quarters · filed 2021-11-05 | ||
| 2020-03-31 | $3.00M 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $11.90M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $3.50M 10-Q · filed 2020-11-06 | $6.10M derived: sum of 2 quarters · filed 2020-11-06 | $8.80M derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $2.60M 10-Q · filed 2020-11-06 | $5.30M derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $2.70M 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $11.30M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $3.30M 10-Q · filed 2019-11-04 | $5.70M derived: sum of 2 quarters · filed 2019-11-04 | $8.20M derived: sum of 3 quarters · filed 2019-11-04 | |
| 2018-06-30 | $2.40M 10-Q · filed 2019-11-04 | $4.90M derived: sum of 2 quarters · filed 2019-11-04 | ||
| 2018-03-31 | $2.50M 10-Q · filed 2019-11-04 | |||
| 2017-12-31 | $11.00M 10-K · filed 2020-03-27 | |||
| 2016-12-31 | $9.40M 10-K · filed 2019-03-01 | |||
| 2015-12-31 | $8.00M 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $9.40M 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $6.60M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $7.80M 10-K · filed 2015-02-27 | |||
| 2011-12-31 | $7.90M 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $6.90M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $6.30M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |